Several telehealth advocates are coming out in support of the Drug Enforcement Administration’s (DEA) third extension of Covid-19 telehealth flexibilities for the prescribing of controlled substances. However, they argue that more work needs to…
Continue Reading
This roundup is meant to highlight some of the most notable funding rounds of the month and is not intended to be comprehensive.
Several major fundraising announcements in the payer/employer space were announced in May….
Continue Reading
Boulder Care, a virtual provider for substance use disorder, has raised $35 million in Series C funding, the company announced Wednesday.
Portland, Oregon-based Boulder Care works with payers — primarily Medicaid — in value-based contracts…
Continue Reading
What You Should Know:
– Boulder Care, a leading provider of high-quality addiction treatment, announced today the successful closing of an oversubscribed $35M Series C funding round led by Advance Venture Partners (AVP), joined by…
Continue Reading
This month, the U.S. Department of Health and Human Services (HHS) and the Substance Abuse and Mental Health Services Administration (SAMHSA) took steps to expand access to opioid use disorder treatment through its new…
Continue Reading
Boulder Care, a virtual provider for substance use disorder, is extending its treatment to adolescents in partnership with UnitedHealthcare Community Plan, the company told MedCity News exclusively.
Portland, Oregon-based Boulder Care works with payers and…
When the Drug Enforcement Administration (DEA) released its proposed rule that would remove some of the Covid-19 telehealth flexibilities for the prescribing of controlled substances, it caused an uproar from telehealth companies and advocates….
Continue Reading
In the 1980s, Haner Hernández only requested to attend a drug treatment program in order to get out of prison. Back then, he was only approved to be released from prison and go into…
Continue Reading
